tiprankstipranks
Nika Pharmaceuticals Inc (NIKA)
OTHER OTC:NIKA
US Market

Nika Pharmaceuticals Inc (NIKA) Financial Statements

5 Followers

Nika Pharmaceuticals Inc Financial Overview

Nika Pharmaceuticals Inc's market cap is currently $431.19M. The company's EPS TTM is $0; its P/E ratio is -5,519.27; Nika Pharmaceuticals Inc is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -76.40K$ -95.79K$ -64.83K$ -3.18M$ -14.71K
EBITDA$ -76.40K$ -95.79K$ -64.83K$ -3.18M$ -14.71K
Net Income$ -76.40K$ -95.79K$ -64.83K$ -3.18M$ -14.71K
Balance Sheet
Cash & Short-Term Investments$ 1.89K$ 2.08K$ 19.60K$ 864.00$ 399.00
Total Assets$ 21.00K$ 17.93K$ 19.60K$ 864.00$ 399.00
Total Debt$ 0.00$ 239.16K$ 101.75K$ 18.18K$ 24.02K
Net Debt$ -1.89K$ 237.08K$ 82.15K$ 17.32K$ 23.62K
Total Liabilities$ 318.62K$ 239.16K$ 101.75K$ 18.18K$ 24.02K
Stockholders' Equity$ -297.63K$ -221.23K$ -82.15K$ -17.32K$ -23.62K
Cash Flow
Free Cash Flow$ -79.65K$ -139.08K$ -64.83K$ -33.72K$ -14.71K
Operating Cash Flow$ -79.65K$ -139.08K$ -64.83K$ -33.72K$ -14.71K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 79.46K$ 137.42K$ 83.56K$ 34.18K$ 13.50K
Currency in USD

Nika Pharmaceuticals Inc Earnings and Revenue History

Nika Pharmaceuticals Inc Debt to Assets

Nika Pharmaceuticals Inc Cash Flow

Nika Pharmaceuticals Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.